• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Knee Bursitis Market

    ID: MRFR/Pharma/3965-HCR
    100 Pages
    Rahul Gotadki
    September 2025

    Knee Bursitis Market Research Report Information: By Diagnosis (Imaging Test (X-Ray, Ultrasound)), Treatment (Medication, Surgery (Corticosteroid Injection)) End User (Hospitals & Clinics, Diagnostic Centers, Research Centers) – Forecast till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Knee Bursitis Market Research Report - Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Knee Bursitis Market Summary

    The Global Knee Bursitis Market is projected to grow significantly from 0.73 USD Billion in 2024 to 5.61 USD Billion by 2035.

    Key Market Trends & Highlights

    Knee Bursitis Key Trends and Highlights

    • The market is expected to exhibit a robust compound annual growth rate (CAGR) of 20.38% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 5.61 USD Billion, indicating substantial growth potential.
    • In 2024, the market is valued at 0.73 USD Billion, reflecting the current demand for knee bursitis treatments.
    • Growing adoption of advanced treatment options due to increasing awareness of knee bursitis is a major market driver.

    Market Size & Forecast

    2024 Market Size 0.73 (USD Billion)
    2035 Market Size 5.61 (USD Billion)
    CAGR (2025-2035) 20.38%

    Major Players

    Novartis AG, Pfizer Inc, Amgen Inc, AVEO Pharmaceuticals Inc, Bayer AG, Bellicum Pharmaceuticals Inc, MediaPharma srl, Merck & Co., Inc, Merrimack Pharmaceuticals Inc, Oncolys BioPharma Inc, United Therapeutics Corp

    Knee Bursitis Market Drivers

    Market Growth Projections

    The Global Knee Bursitis Market Industry is projected to experience substantial growth over the next decade. With a market size of 0.73 USD Billion in 2024, it is anticipated to reach 5.61 USD Billion by 2035. This represents a remarkable compound annual growth rate of 20.38% from 2025 to 2035. Such projections indicate a robust demand for innovative treatment solutions and increased healthcare investments in managing knee bursitis. The market dynamics suggest a favorable environment for stakeholders, including healthcare providers and pharmaceutical companies, to capitalize on emerging opportunities in this evolving landscape.

    Increased Sports Participation

    The surge in sports participation globally is a notable driver for the Global Knee Bursitis Market Industry. As more individuals engage in recreational and competitive sports, the incidence of knee injuries, including bursitis, is likely to rise. Athletes and active individuals are particularly vulnerable to knee bursitis due to repetitive stress and trauma to the knee joint. This trend necessitates a greater demand for preventive measures and treatment options. Consequently, the market is expected to expand as sports-related injuries prompt athletes to seek effective interventions, further solidifying the industry's growth trajectory.

    Rising Awareness and Education

    There is a growing emphasis on awareness and education regarding knee bursitis, which is positively impacting the Global Knee Bursitis Market Industry. Health campaigns and educational programs aim to inform the public about the causes, symptoms, and treatment options for knee bursitis. Increased knowledge can lead to earlier diagnosis and intervention, which is crucial for effective management of the condition. As healthcare providers and organizations continue to promote awareness, more individuals are likely to seek medical help, thereby driving market growth. This trend is expected to contribute to a compound annual growth rate of 20.38% from 2025 to 2035.

    Advancements in Treatment Options

    Innovations in treatment methodologies are significantly influencing the Global Knee Bursitis Market Industry. The development of minimally invasive surgical techniques and advanced physiotherapy practices has improved patient outcomes and reduced recovery times. For example, ultrasound-guided injections have become a standard practice, allowing for precise delivery of corticosteroids to the affected bursa. These advancements not only enhance patient satisfaction but also encourage more individuals to seek treatment, thus expanding the market. As the industry evolves, it is anticipated that the market will grow substantially, potentially reaching 5.61 USD Billion by 2035.

    Increasing Prevalence of Knee Bursitis

    The Global Knee Bursitis Market Industry is experiencing growth due to the rising incidence of knee bursitis among various demographics. Factors such as aging populations and increased participation in sports contribute to this trend. For instance, older adults are particularly susceptible to knee bursitis, which can lead to chronic pain and mobility issues. As awareness of knee bursitis increases, more individuals seek medical attention, thereby driving market demand. This trend is expected to bolster the market, with projections indicating a market size of 0.73 USD Billion in 2024, reflecting the urgent need for effective treatment options.

    Demographic Shifts and Lifestyle Changes

    Demographic shifts, particularly in urbanization and lifestyle changes, are influencing the Global Knee Bursitis Market Industry. As populations migrate to urban areas, sedentary lifestyles become more prevalent, leading to increased obesity rates and joint-related issues. These lifestyle factors contribute to a higher incidence of knee bursitis, as excess weight places additional stress on the knee joints. The market is likely to respond to these demographic changes by offering targeted treatments and preventive strategies. As the population ages and lifestyles evolve, the demand for knee bursitis management solutions is expected to grow, further driving market expansion.

    Key Companies in the Knee Bursitis Market market include

    Future Outlook

    Knee Bursitis Market Future Outlook

    The Global Knee Bursitis Market is projected to grow at a 20.38% CAGR from 2024 to 2035, driven by increasing prevalence, advancements in treatment options, and rising awareness.

    New opportunities lie in:

    • Develop innovative, minimally invasive surgical techniques to enhance patient recovery.
    • Invest in telehealth platforms for remote monitoring and management of knee bursitis.
    • Create targeted marketing campaigns focusing on preventive care and lifestyle modifications.

    By 2035, the Knee Bursitis Market is expected to be robust, reflecting substantial growth and innovation.

    Market Segmentation

    Knee Bursitis Market Segmentation

    Key Players in the Knee Bursitis Market
    • Novartis AG
    • Inc
    • Amgen Inc
    • AVEO Pharmaceuticals Inc
    • Bayer AG
    • Bellicum Pharmaceuticals Inc
    • MediaPharma srl
    • Merck & Co., Inc
    • Merrimack Pharmaceuticals Inc
    • Oncolys BioPharma Inc
    • United Therapeutics Corp 

    Report Scope

    Attribute/Metric Details
    Market Size 2023 0.32 (USD Billion)
    Market Size 2024 0.73 (USD Billion)
    Market Size 2032 4.57 (USD Billion)
    Compound Annual Growth Rate (CAGR) 7.1 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Novartis AG, Pfizer Inc, Amgen Inc, AVEO Pharmaceuticals Inc, Bayer AG, Bellicum Pharmaceuticals Inc, MediaPharma srl, Merck & Co., Inc, Merrimack Pharmaceuticals Inc, Oncolys BioPharma Inc, United Therapeutics
      Key Market Opportunities ·  High healthcare expenditure·  Well-developed technology
      Key Market Drivers   Increasing prevalence of bone-related disorders and reimbursement schemes covering treatment costs

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the expected growth rate of the global knee bursitis market?

    Knee bursitis market can exhibit a CAGR of 7.10% from 2024 to 2032.

    What are the growth enablers of the global knee bursitis market?

    Increasing prevalence of bone-related disorders and reimbursement schemes covering treatment costs are major drivers of the global knee bursitis market.

    What factors can restrain the global knee bursitis market?

    Stringent regulations and high costs of treatments can restrain the global knee bursitis market.

    Which region can dominate the global knee bursitis market?

    The Americas can dominate the global knee bursitis market till 2032.

    Name the key players of the global knee bursitis market?

    Merck & Co., Inc, AVEO Pharmaceuticals Inc, Pfizer Inc, United Therapeutics Corp, MediaPharma srl, Merrimack Pharmaceuticals Inc, Novartis AG, Bayer AG, Oncolys BioPharma Inc, Amgen Inc, and Bellicum Pharmaceuticals Inc are key players of the global knee bursitis market.

    Knee Bursitis Market Research Report - Forecast till 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials